Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 26, Issue 1, Pages 119-124Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2015.03.021
Keywords
jolkinolide B; Acute lung injury; NF-kappa B; MAPK
Categories
Funding
- National Natural Science Foundation of China [21175055, 81472030, 81472454, 31100930]
- Natural Science Foundation of Jilin Provincial Science & Technology Department, China [20150204001YY, 2011713, 20090461, 20110739, 20130413017GH]
- Norman Bethune Program of Jilin University [2012210]
Ask authors/readers for more resources
Jolkinolide B (JB), an ent-abietane diterpenoid, isolated from the dried root of Euphorbia fischeriana, has been reported to have potent anti-tumor and anti-inflammatory activities. However, the effects of JB on acute lung injury (ALI) and underlying molecular mechanisms have not been investigated. The present study aimed to investigate the effect of JB on lipopolysaccharide (LPS)-induced ALI. Male C57BL/6 mice were pretreated with dexamethasone or JB 1 h before intranasal instillation of LPS. The results showed that JB markedly attenuated LPS-induced histological alterations, lung edema, inflammatory cell infiltration, myeloperoxidase (MPO) activity as well as the production of TNE-alpha, IL-6 and IL-1 beta. Furthermore, JB also significantly inhibited LPS-induced the degradation of I kappa B alpha. and phosphorylation of NF-kappa B p65 and MAPK. Therefore, our study provides the first line of evidence that pretreatment of JB has a protective effect on LPS-induced ALI in mice. The anti-inflammatory mechanism of JB may be attributed to its suppression of NF-kappa B and MAPK activation. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available